A dual-functional PSMA and 2-deoxy-D-glucose (2DG) dendrimer system (PSMA-2DG-D) further enhanced the tumor accumulation and efficacy of cabozantinib while reducing systemic toxicity [234]. The gene discussed is FOLH1; the disease is neoplasm.